Beware of fake advertisements on social media using the SGH logo to promote products. SGH does NOT promote, advertise, or endorse any particular brand or product in accordance with the Healthcare Services Act. Stay vigilant and ignore these fake advertisements.

Dr Samuel Ee Cheng En

MBBS, MRCP (UK), MMed (Internal Medicine)

Associate Consultant

Changi General Hospital Changi General Hospital

Specialty: Geriatric Medicine

Conditions Treated By This Doctor

Clinical Appointments

Associate Consultant

Geriatric Medicine

About

Dr Samuel Ee is an Associate Consultant with the Department of Geriatric Medicine at Changi General Hospital (CGH).

He graduated with a Bachelor of Medicine and Surgery from the National University of Singapore (NUS) Yong Loo Lin School of Medicine in 2016. He obtained his MRCP (UK) and MMed (Internal Medicine) in 2018. He completed his training in Internal Medicine and Geriatric Medicine with SingHealth in 2022.

His interests include that of improving and innovating the delivery of geriatric care in both the hospital and community settings, as well as medical education.

Education and Training

  • MMed Internal Medicine (Singapore) 2018
  • MRCP (UK) 2018
  • MBBS National University of Singapore 2016

Professional Appointments and Committee Memberships

  • Associate Consultant, Department of Geriatric Medicine, Changi General Hospital 2022 – Present

Awards

  • CGH Improvement Festival, Silver Award, 2022
  • SingHealth Duke-NUS Quality and Innovation Day, Poster Excellence, 2022

Publications

  • Lam, Justina & Choo, Su-Pin & Tai, David & Tan, Iain & Tham, Chee & Koo, Wen & Ong, Simon & Ang, Soo & Chua, Clarinda & Chong, Dawn & Teo, Patrick Tze Hern & Lee, Christabel & Ee, Samuel & Ng, Matthew. (2019). What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center. Asia-Pacific Journal of Clinical Oncology. 16. 10.1111/ajco.13285
  • Chohan SA, Balasubramanian D, Ee S. Bullous pemphigoid-like skin rash associated with Rivaroxaban use in a very elderly patient with multimorbidity and chronic kidney disease: A case report. Clin Case Rep. 2020;00:1–6. https://doi.org/10.1002/ccr3.2757